Real-world disease burden and planned treatment optimization after MANAGE-PD implementation in Germany: a cross-sectional study

Table 2 Information about options and eligibility for DAT by categories of disease control (MANAGE-PD tool)

		Disease control categorization by MANAGE-PD tool
		Category 1 (n = 50)	Category 2 (n = 125)	Category 3 (n = 103)
Patient is informed about DAT options, n (%)	Yes	18 (36.0)	65 (52.0)	63 (61.2)
Patient is informed about DAT options, n (%)	No	32 (64.0)	60 (48.0)	40 (38.8)
Eligible for DAT (physician’s assessment), n (%)	Yes	6 (12.0)	41 (32.8)	78 (75.7)
Eligible for DAT (physician’s assessment), n (%)	No	44 (88.0)	84 (67.2)	25 (24.3)

Category 1: Currently well controlled, Category 2: Inadequately controlled—might benefit from further oral optimization, Category 3: Inadequately controlled—might benefit from DAT. DAT, device-aided therapy; N/n: number of patients

ISSN: 2524-3489